Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

NCT07325435 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes (T2DM)

Interventions

DRUG: SGLT-2 inhibitor
DRUG: GLP1-RA

Sponsor

MaryAnn Banerji

Collaborators

[object Object]